Merck Recalls TEMODAR® and Temozolomide Bottles with Cracked Caps Due to Failure to Meet Child–Resistant Closure Requirement
Dateline City:
KENILWORTH, N.J.
Patients Should Visually Examine Bottle Caps for Cracks and if Cracks are Found, Ensure the Bottles are Stored Out of the Reach of Children
Replacement Caps for Patients Are Available
Medication Within the Bottles Is Not Affected; Patients May Continue to Take Their Medicine as Prescribed
KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, in
conjunction with the U.S. Consumer Product Safety Commission (CPSC)
today asked that all customers, including patients, inspect all bottles
of TEMODAR® (temozolomide) capsules and all bottles of Temozolomide
capsules (generic) for potential cracks in the child-resistant bottle
caps. The medicine is manufactured by Merck and distributed in the
United States by Merck as TEMODAR.
Language:
English
Contact:
MerckMedia:Pamela Eisele, 267-305-3558orSkip Irvine, 215-652-6059orInvestors:Justin Holko, 908-740-1879
Ticker Slug:
Ticker: MRK Exchange: NYSE
read more
Source: Merck.com - Product News - Category: Drugs & Pharmacology Tags: Oncology Newsroom Prescription Medicine News Corporate News Latest News Source Type: news